Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2030)	11/8/2007 12:13:36 PM
From: Jibacoa	Respond to of 3722

SOMX seems to have found support at the $5.50 level after its recent drop from the $9 level.<g> bigcharts.marketwatch.com Its PIII of Silenor for insomnia demonstrated statistically significant improvements on multiple endpoints measuring sleep onset, sleep maintenance and the prevention of early morning awakenings, it also reported a favorable safety and tolerability profile & a low discontinuation rate with no evidence of dependency, withdrawal, tolerance or amnesia. SOMX expects that the drug won't be scheduled as a controlled substance & thinks that it has the potential to capture a share of the insomnia market,as they expect to launch it in 2009, but first they need to submit the NDA to the FDA.<g> The FDA has requested that data from the genotoxicity studies & reproductive toxicology studies should be included in the NDA & depending on those results it may or not request carcinogenicity studies before NDA approval. SOMX has no significant LTD, the insiders reportedly hold around 30% & the institutions, including BAC & JPM, around 70% (JPM upgraded the stock today from "underperform" to "neutral".<g>) finance.yahoo.com The short position which increased about 60% in the last month,is still around 6x its ADV. At any rate, the stock is up today > 11% in spite of the general market, but still trading at a level substantially below its IPO price in Dec 2005.<g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2030)	12/21/2007 12:30:56 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

After forming a little bas at the $8 level, SQNM is taking advantage of today's market to try to test the resistance at the $9 level.<g> The stock is up 6.25%.It still needs to close above $10 in order to test its Oct 17 H at $11.63 & resume its previous UT. bigcharts.marketwatch.com But with some further news, the stock should be able to move well, since it has plenty of room to run once it gets back again in the double digits range.<g> bigcharts.marketwatch.com Bernard